Tag: CORO
Two Doses of BNT162b2 Moderately Effective for 5- to 11-Year-Olds
Moderate effectiveness against documented infection and symptomatic COVID-19 for those vaccinated on or after Nov. 23, 2021
COVID-19 Linked to Increased Risk of Neurological Disorders
Most neurological disorders do not appear to be more frequent after COVID-19 than after influenza or bacterial pneumonia
ACIP Recommends COVID-19 Vaccines for Children Aged ≥6 Months
ACIP interim recommendations presented for Moderna, Pfizer-BioNTech mRNA vaccines for children aged 6 months to 5 years
FDA Panel Supports Rollout of Tweaked Booster Shots From Moderna, Pfizer This Fall
Advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations
Vaccines Estimated to Have Prevented 19.8 Million COVID-19 Deaths
More deaths would have been averted had vaccine coverage targets from COVAX and WHO been met
Fatigue, Brain Fog, Anxiety Prevalent With Long COVID
Significant associations seen for concentration and attention, as well as memory issues, with complaint of brain fog
SARS-CoV-2-Linked Hospitalization, ED Encounters Rare After Paxlovid
<1 percent of patients to whom Paxlovid was dispensed for mild-to-moderate COVID-19 had hospitalization or ED encounter
Pfizer Has Two Updated Booster Shots to Help Fight Omicron
Company said Saturday that it was confident its new booster candidates are better than their predecessor
FDA Panel to Weigh Improved Booster Shots From Moderna, Pfizer
Both Pfizer and Moderna have been testing updated booster shots that target the omicron variant
Fourth Dose of BNT162b2 Prevents Severe COVID-19 in Nursing Home Residents
Substantial protection against hospitalizations, deaths seen among long-term care facility residents during omicron surge
